Lenalidomide is safe and active in <scp>W</scp>aldenström macroglobulinemiaGuillemette Fouquet, Xavier Leleu, Charles Herbaux et al.|American Journal of Hematology|2015Cited by 26
Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014‐04 (Etoile du Nord) trialEileen M. Boyle, Xavier Leleu, Marie‐Odile Petillon et al.|British Journal of Haematology|2019Cited by 23
Ixazomib, pomalidomide and dexamethasone in relapsed or refractory multiple myeloma characterized with high-risk cytogenetics: the IFM 2014-01 studyArthur Bobin, Xavier Leleu, Salomon Manier et al.|Haematologica|2024Cited by 3
Ixazomib, Pomalidomide and Dexamethasone (IxPd) in Relapsed or Refractory Multiple Myeloma (RRMM) Characterized with High-Risk Cytogenetics. IFM 2014-01Arthur Bobin, Xavier Leleu, Salomon Manier et al.|Blood|2023Cited by 0